Nenufar

Showing posts with label Argonaute. Show all posts
Showing posts with label Argonaute. Show all posts

Sunday, August 14, 2016

CRSPR - Cas9 alternative Argonaute

Anyone working with Argonaute?  Results?  Pass or fail?



http://blog.addgene.org/comparing-cas9-to-ngago-can-the-argonautes-best-crispr






Posted by nenufar molecules at 12:47 PM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Labels: Argonaute, CRISPR-cas9, gene editing, molecular biology
Older Posts Home
Subscribe to: Posts (Atom)

About Me

nenufar molecules
View my complete profile

Blog Archive

  • ▼  2025 (1)
    • ▼  February (1)
      • In memory of our friend David Johnson
  • ►  2024 (8)
    • ►  December (1)
    • ►  November (1)
    • ►  September (1)
    • ►  August (1)
    • ►  July (2)
    • ►  April (1)
    • ►  January (1)
  • ►  2023 (14)
    • ►  December (1)
    • ►  November (2)
    • ►  October (3)
    • ►  September (2)
    • ►  August (1)
    • ►  July (1)
    • ►  June (2)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (11)
    • ►  November (3)
    • ►  October (1)
    • ►  September (1)
    • ►  July (3)
    • ►  April (1)
    • ►  February (1)
    • ►  January (1)
  • ►  2021 (8)
    • ►  December (1)
    • ►  October (1)
    • ►  September (1)
    • ►  June (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (1)
  • ►  2020 (1)
    • ►  December (1)
  • ►  2018 (3)
    • ►  October (1)
    • ►  August (1)
    • ►  April (1)
  • ►  2017 (22)
    • ►  December (1)
    • ►  November (1)
    • ►  September (2)
    • ►  August (4)
    • ►  July (1)
    • ►  June (1)
    • ►  May (3)
    • ►  April (4)
    • ►  March (1)
    • ►  February (2)
    • ►  January (2)
  • ►  2016 (83)
    • ►  December (2)
    • ►  November (5)
    • ►  October (6)
    • ►  September (10)
    • ►  August (8)
    • ►  July (5)
    • ►  June (15)
    • ►  May (14)
    • ►  April (4)
    • ►  March (3)
    • ►  February (4)
    • ►  January (7)
  • ►  2015 (5)
    • ►  December (3)
    • ►  November (2)
Awesome Inc. theme. Powered by Blogger.